Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 1, 2006

Biofusion to Commercialize all Cardiff University IP

  • The University of Cardiff gained a £17-million equity stake in Biofusion, in return for exclusive rights for 10 years to commercialize 100% of all Cardiff University research-generated IP.

    The company claims the agreement will allow Cardiff University to triple its research spending, to some £1 billion over the 10 years. Through the life of the deal Biofusion will also take over Cardiff University’s shares in seven existing spin-out companies and will have 100% ownership of all future Cardiff University spin-outs.



Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »